Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture.
Troubled artificial heart
maker Carmat is appealing to key shareholders led by
Airbus to invest new funds to avoid the collapse of the
30-year-old venture dating back to a chance meeting between.
Artificial heart maker Carmat's future seen in hands of core backers reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
By Michal Aleksandrowicz, Tim Hepher and Laura Lenkiewicz PARIS (Reuters) - Troubled artificial heart maker Carmat is appealing to key shareholders le.
Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript September 21, 2023 Valneva SE misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.36. Operator: Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call and Webcast. [Operator Instructions] Please note that today’s conference is being […]